Agibot takes on Tesla with needle-threading humanoid robots

Tesla has been hyping Optimus for years, but a well-funded challenger in China is trying to beat Elon Musk to the commercial finish line.

Shanghai-based robotics startup Agibot unveiled an entire family of next-generation humanoid robots. The company was founded by Peng Zhihui, a 31-year-old former member of Huawei's prestigious "Genius Youth" recruitment program, and is backed by venture capital heavyweight HongShan.

Peng declared during the online launch that the company has made major breakthroughs over the past year and is now sitting at the forefront of the robotics industry.

From needle threading to five new models

Instead of showing off a single prototype, Agibot introduced five distinct models across both wheeled and bipedal form factors, targeting everything from household chores to factory floors.

The headliner of the lineup is the Yuanzheng A2, a bipedal humanoid robot standing 175 centimeters tall and weighing 55 kilograms. Packed with diverse sensors and powered by multimodal AI, it can see, hear, and process text, audio, and visual data simultaneously.

Agibot claims the robot is dextrous enough to handle delicate physical tasks, such as inserting a thread through the eye of a needle.

Racing Tesla with 300 deliveries planned

While robot demos are a dime a dozen, Agibot is already committing to aggressive commercial timelines.

Company executive Jiang Qingsong told digital outlet The Paper that Agibot plans to begin customer shipments in October, aiming to deliver 300 units by the end of the year.

Agibot is explicitly gunning for Tesla. During Tesla's annual shareholder meeting in June, Musk hinted that Optimus could go on sale by late next year while serving duty inside Tesla factories beforehand.

Jiang told financial outlet cls.cn that Agibot does not expect a significant performance gap between the two platforms, boldly asserting that Agibot's commercialization and cost-control capabilities are superior to Tesla's.

Why it matters

For enterprise customers, 300 units by year-end is a real-world stress test. If Agibot can deliver functional units into production environments this fall, it shifts humanoids out of research labs and into commercial pilot operations well ahead of Western competitors.

For the broader industry, this escalation highlights the core dynamic of the US-China robotics race. While Silicon Valley leads in frontier foundational AI, Chinese hardware teams are leaning heavily into domestic supply-chain density and rapid manufacturing velocity.

We think Agibot's decision to mix wheeled and bipedal models is clever, allowing them to monetize simpler mobile manipulation while bipedal walking matures. However, claiming superior cost control against Tesla is a high-stakes bet. Delivering 300 humanoids in just a few months is an operational nightmare, and threading a needle in a keynote video is wildly different from working eight-hour factory shifts without human intervention.